Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Icon plc, headquartered in Ireland (IE), is a leading player in the research and development services industry, specifically within the realm of clinical research. Founded in 1990, Icon has established itself as a trusted partner for pharmaceutical, biotechnology, and medical device companies, offering a comprehensive suite of services that span the entire drug development lifecycle.
With a strong presence in North America, Europe, and Asia, Icon excels in providing innovative solutions that enhance clinical trial efficiency and patient engagement. Their core offerings include clinical trial management, regulatory consulting, and data analytics, all designed to streamline the development process and improve outcomes. Icon's commitment to quality and innovation has positioned it as a market leader, recognised for its ability to adapt to the evolving needs of the healthcare sector.
+47 vs industry average
Icon’s score of 80 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
In 2024, ICON's total reported carbon emissions were approximately 361,809 tonnes CO2e. This includes about 2,357 tonnes CO2e from Scope 1 emissions, 2,469 tonnes CO2e from Scope 2 market-based emissions, and 356,983 tonnes CO2e from Scope 3 emissions. Key contributors to Scope 3 emissions included purchased goods and services (approximately 191,013 tonnes CO2e), business travel (approximately 60,690 tonnes CO2e), and employee commute (approximately 33,686 tonnes CO2e).
ICON, a Research and development services company headquartered in Ireland, has set ambitious climate commitments validated by the Science Based Targets initiative (SBTi). The company is committed to reaching net-zero greenhouse gas emissions across its entire value chain by FY2050.
Near-term targets include a 61.2% absolute reduction in Scope 1 and 2 GHG emissions by FY2028, against a FY2019 base year. Additionally, ICON aims to achieve a 20.0% absolute reduction in Scope 3 GHG emissions by FY2028, using a FY2022 base year.
For long-term goals, ICON is committed to a 90.0% absolute reduction in Scope 1 and 2 GHG emissions by FY2050 from a FY2019 base year, and a 90.0% absolute reduction in Scope 3 GHG emissions by FY2050 from a FY2022 base year.
2050
90% reduction in Scope 2
ICON plc commits to reduce absolute scope 1 and 2 GHG emissions 90.0% by FY2050 from a FY2019 base year.
2028
61.2% reduction in Scope 2
ICON plc commits to reduce absolute scope 1 and 2 GHG emissions 61.2% by FY2028 from a FY2019 base year.
2028
20% reduction in scope 3 total
ICON plc also commits to reduce absolute scope 3 GHG emissions 20.0% by FY2028 from a FY2022 base year.
See all 7 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Icon’s sustainability data and climate commitments
Data year: 2024
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more